ATG14 and acute myeloid leukemia: miR-15a-5p, which is overexpressed in chemoresistant AML patients [152], has been discovered to target ATGs (ATG9A, ATG14, GABARAPL1, and SMPD1) to induce chemoresistance in AML cells [153].